Milademetan

  • CAT Number: I012065
  • CAS Number: 1398568-47-2
  • Molecular Formula: C30H34Cl2FN5O4
  • Molecular Weight: 618.531
  • Purity: ≥95%
Inquiry Now

Milademetan (CAT: I012065) is a potent and selective inhibitor of MDM2, a protein that negatively regulates the tumor suppressor protein p53. By inhibiting the interaction between MDM2 and p53, milademetan promotes p53 activation and stabilization, leading to cell cycle arrest, apoptosis, and inhibition of tumor growth. Milademetan has demonstrated efficacy in preclinical models and is being investigated as a potential treatment for various p53 wild-type solid tumors and hematological malignancies. Clinical trials are underway to evaluate the safety and efficacy of milademetan as a targeted therapy for cancer.

Catalog Number I012065
CAS Number 1398568-47-2
Molecular Formula

C30H34Cl2FN5O4

Purity 95%
Storage Room temperature
InChI InChI=1S/C30H34Cl2FN5O4/c1-28(2)8-10-29(11-9-28)30(18-5-3-15(31)13-19(18)37-27(30)41)21(17-7-12-35-24(32)22(17)33)23(38-29)26(40)36-16-4-6-20(25(34)39)42-14-16/h3,5,7,12-13,16,20-21,23,38H,4,6,8-11,14H2,1-2H3,(H2,34,39)(H,36,40)(H,37,41)/t16-,20+,21+,23-,30-/m1/s1
InChIKey RYAYYVTWKAOAJF-QISPRATLSA-N
SMILES CC1(CCC2(CC1)C3(C(C(N2)C(=O)NC4CCC(OC4)C(=O)N)C5=C(C(=NC=C5)Cl)F)C6=C(C=C(C=C6)Cl)NC3=O)C

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!